Page last updated: 2024-10-20

thiamine and Breast Neoplasms

thiamine has been researched along with Breast Neoplasms in 12 studies

thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"In previous studies, we have shown that RNA levels of the thiamine transporter THTR2 were down-regulated in breast cancer tumors in comparison with normal tissues and that THTR2-mediated increases in thiamine uptake activity contributed to increased apoptosis after exposure to ionizing radiation."7.72Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. ( Liu, S; Moscow, JA; Stromberg, A; Tai, HH, 2004)
"THTR2 RNA levels were down-regulated in breast cancer to 14% of the level found in corresponding normal tissues, while THTR1 levels were unchanged."5.32Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. ( Comesse, S; Golinski, M; Grossman, RB; Huang, H; Liu, S; Lu, X; Moscow, JA; Watt, D, 2003)
"In previous studies, we have shown that RNA levels of the thiamine transporter THTR2 were down-regulated in breast cancer tumors in comparison with normal tissues and that THTR2-mediated increases in thiamine uptake activity contributed to increased apoptosis after exposure to ionizing radiation."3.72Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. ( Liu, S; Moscow, JA; Stromberg, A; Tai, HH, 2004)
"Employing cDNA arrays of breast cancer and normal breast epithelial tissues, SLC19A2, SLC25A19 and TPK-1 were found to be significantly up-regulated."1.39Up-regulation of vitamin B1 homeostasis genes in breast cancer. ( Bartlett, MG; Govindarajan, R; Hanberry, BS; McGinnis, AC; Sweet, RL; Venuti, KR; Zastre, JA, 2013)
"THTR2 RNA levels were down-regulated in breast cancer to 14% of the level found in corresponding normal tissues, while THTR1 levels were unchanged."1.32Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. ( Comesse, S; Golinski, M; Grossman, RB; Huang, H; Liu, S; Lu, X; Moscow, JA; Watt, D, 2003)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19904 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Dhanani, LY1
Totton, RR1
Jara-Quijada, E1
Pérez-Won, M1
Tabilo-Munizaga, G1
Lemus-Mondaca, R1
González-Cavieres, L1
Palma-Acevedo, A1
Herrera-Lavados, C1
Milovanovic, S1
Grzegorczyk, A1
Świątek, Ł1
Grzęda, A1
Dębczak, A1
Tyskiewicz, K1
Konkol, M1
Li, Y2
Chang, P1
Sankaran, S1
Jang, H1
Nie, Y1
Zeng, A1
Hussain, S1
Wu, JY1
Chen, X2
Shi, L2
Senapati, A1
Chetri, BK1
Mitra, S1
Shelke, RG1
Rangan, L1
Chauhan, AS1
Tiwari, M1
Indoliya, Y1
Mishra, SK1
Lavania, UC1
Chauhan, PS1
Chakrabarty, D1
Tripathi, RD1
Akaputra, R1
Hatta, M1
Massi, MN1
Djaharuddin, I1
Bukhari, A1
Aminuddin, A1
Santoso, A1
Natzir, R1
Bahar, B1
Fachri, M1
Farsida, F1
Fathimah, A1
Ubaidah, FM1
Sridiana, E1
Dwiyanti, R1
Syukri, A1
Junita, AR1
Febrianti, A1
Primaguna, MR1
Azhar, A1
Rajaure, YS1
Thapa, B1
Budhathoki, L1
Rana, SR1
Khadka, M1
Batchu, UR1
Surapaneni, JR1
Cheemalamarri, C1
Mandava, K1
Puvvada, N1
Shetty, PR1
Mv, S1
Ranjbarian, P1
Goudarzi, F1
Akya, A1
Heidarinia, H1
Farasat, A1
Rostamian, M1
Suri, K1
Rajput, N1
Sharma, P1
Omble, AD1
Kulkarni, K1
Gahlay, GK1
Fernandez Garcia, E1
Paudel, U1
Noji, MC1
Bowman, CE1
Rustgi, AK1
Pitarresi, JR1
Wellen, KE1
Arany, Z1
Weissenrieder, JS1
Foskett, JK1
Lee, MS1
Han, HJ1
Choi, TI1
Lee, KH1
Baasankhuu, A1
Kim, HT1
Kim, CH1
Redd, PS1
Payero, L1
Gilbert, DM1
Page, CA1
King, R1
McAssey, EV1
Bodie, D1
Diaz, S1
Hancock, CN1
Lee, HS1
Jung, S1
Lee, SW1
Kim, YT1
Lee, J1
Ren, T1
Yu, Z1
Yu, H1
Deng, K1
Wang, Z1
Li, X1
Wang, H1
Wang, L2
Xu, Y1
Lascano, J1
Riley, L1
Khodayari, N1
Brantly, M1
Gupta, R1
Pradhan, J1
Haldar, A1
Murapaka, C1
Chandra Mondal, P1
Gao, R1
Dai, TY1
Meng, Z1
Sun, XF1
Liu, DX1
Shi, MM1
Li, HR1
Kang, X1
Bi, B1
Zhang, YT1
Xu, TW1
Yan, JM1
Jiang, Q1
Helmchen, G1
Guo, H1
Xiang, W1
Fang, Y1
Li, J4
Lin, Y1
An, X1
Jiang, D1
Cao, Q1
Xu, F1
Shiigi, H1
Wang, W1
Chen, Z1
Akosman, I1
Kumar, N1
Mortenson, R1
Lans, A1
De La Garza Ramos, R1
Eleswarapu, A1
Yassari, R1
Fourman, MS1
Jana, S1
Evans, EGB1
Jang, HS1
Zhang, S2
Zhang, H1
Rajca, A1
Gordon, SE1
Zagotta, WN1
Stoll, S1
Mehl, RA1
Miller, S1
Lee, DA1
Muhimpundu, S1
Maxwell, CA1
Liu, Z1
Shen, F1
Tong, Q1
Tang, M1
Peng, M1
Jiao, Z1
Jiang, Y1
Ao, L1
Fu, W1
Lv, X1
Jiang, G1
Hou, L1
Tu, WC1
McManamen, AM1
Su, X1
Jeacopello, I1
Takezawa, MG1
Hieber, DL1
Hassan, GW1
Lee, UN1
Anana, EV1
Locknane, MP1
Stephenson, MW1
Shinkawa, VAM1
Wald, ER1
DeMuri, GP1
Adams, KN1
Berthier, E1
Thongpang, S1
Theberge, AB1
Jiang, L1
Li, Z1
Dong, Q1
Rong, X1
Dong, G1
Huang, J1
Liang, Y1
Sun, S1
Zhang, R1
Miao, Z1
Senju, C1
Nakazawa, Y1
Oso, T1
Shimada, M1
Kato, K1
Matsuse, M1
Tsujimoto, M1
Masaki, T1
Miyazaki, Y1
Fukushima, S1
Tateishi, S1
Utani, A1
Murota, H1
Tanaka, K1
Mitsutake, N1
Moriwaki, S1
Nishigori, C1
Ogi, T1
Liu, C1
Zhang, X1
Wang, B1
Luo, Z1
Qian, D1
Liu, J1
Waterhouse, GIN1
Barbosa, M1
Marques-Sá, J1
Carvalho, C1
Fernandes, V1
Grilli, D1
Smetana, V1
Ahmed, SJ1
Shtender, V1
Pani, M1
Manfrinetti, P1
Mudring, AV1
Kuang, Y1
Yang, D1
Gai, S1
He, F1
An, B1
Yang, P1
Notini, L1
Schulz, K1
Kubeneck, LJ1
Grigg, ARC1
Rothwell, KA1
Fantappiè, G1
ThomasArrigo, LK1
Kretzschmar, R1
Siswanto, FM1
Okukawa, K1
Tamura, A1
Oguro, A1
Imaoka, S1
Kim, CG1
Jung, M1
Kim, HS1
Lee, CK1
Jeung, HC1
Koo, DH1
Bae, WK1
Zang, DY1
Kim, BJ1
Kim, H1
Yun, UJ1
Che, J1
Park, S1
Kim, TS1
Kwon, WS1
Park, J1
Cho, SW1
Nam, CM1
Chung, HC1
Rha, SY1
Colombo, N1
Van Gorp, T1
Matulonis, UA1
Oaknin, A1
Grisham, RN1
Fleming, GF1
Olawaiye, AB1
Nguyen, DD1
Greenstein, AE1
Custodio, JM1
Pashova, HI1
Tudor, IC1
Lorusso, D1
Zhou, F1
Jiang, Z1
Liang, H1
Ru, S1
Bettiol, AA1
Gao, W1
Lipsyc-Sharf, M1
Jain, E1
Collins, LC1
Rosenberg, SM1
Ruddy, KJ1
Tamimi, RM1
Schapira, L1
Come, SE1
Peppercorn, JM1
Borges, VF1
Warner, E1
Snow, C1
Krop, IE1
Kim, D1
Weiss, J1
Zanudo, JGT1
Partridge, AH1
Wagle, N1
Waks, AG1
Moskowitz, A1
Berg, KM1
Grossestreuer, AV2
Balaji, L1
Liu, X2
Cocchi, MN1
Chase, M1
Gong, MN1
Gong, J1
Parikh, SM1
Ngo, L1
Berlin, N1
Donnino, MW2
Zhou, Y1
Chen, Q1
Zhong, S1
Liu, H1
Koh, K1
Chen, H1
He, J1
Chen, J1
Liu, S4
Lin, L1
Zhang, Y1
Xiao, S1
Cao, S1
Yan, B2
Deng, J1
Gu, J1
Tao, Y1
Huang, C1
Lai, C1
Yong, Q1
Shen, Y1
Gong, Z1
Cao, J1
Mao, W1
Yao, Y1
Zhao, J1
Li, Q1
Liu, K1
Liu, B1
Feng, S1
Chandran, V1
Kunjan, C1
Veerapandian, V1
Kannan, R1
Zhang, T1
von Gunten, U1
Caruso, FR1
Goulart, CDL1
Jr, JCB1
de Oliveira, CR1
Mendes, RG1
Arena, R1
Borghi-Silva, A1
Carrasco-Nuñes, N1
Romano, M1
Cabeza, M1
Jiang, B1
Chen, D1
Zhao, C1
Ma, Y1
Yang, W1
Shen, X1
Satheeshkumar, K1
Saravanakumar, P1
Kalavathi, A1
Vennila, KN1
Elango, KP1
Mues Genannt Koers, L1
Prevost, D1
Paulssen, E1
Hoehr, C1
Ulhassan, Z1
Yang, S1
He, D1
Khan, AR1
Salam, A1
Azhar, W1
Muhammad, S1
Ali, S1
Hamid, Y1
Khan, I1
Sheteiwy, MS1
Zhou, W1
Wang, X1
Xie, Q1
Wang, Y1
Lü, H1
Fu, M1
Wang, D1
Egnell, M1
Fassier, P1
Lécuyer, L1
Zelek, L1
Vasson, MP1
Hercberg, S1
Latino-Martel, P1
Galan, P1
Deschasaux, M1
Touvier, M1
Montissol, S1
Uber, A1
Ganley, S1
Berg, K1
Heydrick, S1
Zastre, JA1
Hanberry, BS1
Sweet, RL1
McGinnis, AC1
Venuti, KR1
Bartlett, MG1
Govindarajan, R1
Miriyala, S1
Keaton, MA1
Jordan, CT1
Wiedl, C1
Clair, DK1
Moscow, JA3
Kim, S1
Rhee, JK1
Yoo, HJ1
Lee, HJ1
Lee, EJ1
Lee, JW1
Yu, JH1
Son, BH1
Gong, G1
Kim, SB1
Singh, SR1
Ahn, SH1
Chang, S1
Huang, H1
Lu, X1
Golinski, M1
Comesse, S1
Watt, D1
Grossman, RB1
Stromberg, A1
Tai, HH1
Basu, TK2
Renwick, S1
Dickerson, JW1
Ogaĭ, SV1
Bogatyrev, AG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of De-Novo Algorithm and Formula in the Treatment of Patients With Intractable Chronic Craniofacial Neuralgia, or Chronic Migraine Headaches.[NCT03220113]Phase 1/Phase 2100 participants (Anticipated)Interventional2017-07-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for thiamine and Breast Neoplasms

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Sexuality research & social policy : journal of NSRC : SR & SP, 2023, Apr-05

    Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Com

2023

Other Studies

11 other studies available for thiamine and Breast Neoplasms

ArticleYear
B-Vitamin Intake from Diet and Supplements and Breast Cancer Risk in Middle-Aged Women: Results from the Prospective NutriNet-Santé Cohort.
    Nutrients, 2017, May-13, Volume: 9, Issue:5

    Topics: Aged; Alcohol Drinking; Breast Neoplasms; Diet; Dietary Supplements; Exercise; Female; Follow-Up Stu

2017
The Effects of Thiamine on Breast Cancer Cells.
    Molecules (Basel, Switzerland), 2018, 06-16, Volume: 23, Issue:6

    Topics: Anaerobiosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Culture Media; Dose-Response Rela

2018
Up-regulation of vitamin B1 homeostasis genes in breast cancer.
    The Journal of nutritional biochemistry, 2013, Volume: 24, Issue:9

    Topics: Biological Transport; Breast Neoplasms; Cell Line, Tumor; Epithelial Cells; Female; Gene Expression

2013
Metabolic effects of acute thiamine depletion are reversed by rapamycin in breast and leukemia cells.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Animals; Antibiotics, Antineoplastic; Breast Neo

2014
Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer.
    Cancer letters, 2015, Feb-28, Volume: 357, Issue:2

    Topics: Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Chromatography, Liquid; Computational Biology

2015
Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis.
    Molecular cancer research : MCR, 2003, Volume: 1, Issue:9

    Topics: Apoptosis; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expressio

2003
Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
    Molecular cancer research : MCR, 2004, Volume: 2, Issue:8

    Topics: Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Gene Expression Profiling; G

2004
The significance of ascorbic acid, thiamin and retinol in cancer.
    International journal for vitamin and nutrition research. Supplement = Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Supplement, 1983, Volume: 24

    Topics: Animals; Ascorbic Acid; Breast Neoplasms; Fluorouracil; Humans; Lung Neoplasms; Mice; Neoplasms; Neo

1983
Modern management of benign mammary dysplasia.
    The Medical journal of Australia, 1979, Jun-16, Volume: 1, Issue:12

    Topics: Adult; Breast Neoplasms; Diuretics; Female; Humans; Precancerous Conditions; Progesterone; Prolactin

1979
The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas.
    Oncology, 1976, Volume: 33, Issue:5-6

    Topics: Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Female; Humans; Male; Middle Aged; Thiamine; Tra

1976
[Urinary excretion of thiamine and riboflavin in oncological patients during the preoperative period].
    Voprosy onkologii, 1974, Volume: 20, Issue:9

    Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Intestinal Neoplasms; Leiomyoma; Male; Middle Aged; N

1974